Proteomic typing of amyloid deposits in systemic amyloidoses

Francesca Lavatelli1, Julie A Vrana

  • 1Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Italy. francesca.lavatelli@unipv.it

Insights

Proteomics, the study of proteins, offers a powerful new method for accurately identifying the specific protein causing amyloidosis. This advanced technique improves diagnosis and management of these complex protein-misfolding diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Clinical Diagnostics

Background:

  • Amyloidoses involve extracellular deposits of misfolded proteins, with over 28 identified causative agents in humans.
  • Accurate typing of amyloid deposits is crucial for disease management.
  • Traditional immunohistochemistry methods for amyloid typing have limitations.

Purpose of the Study:

  • To review alternative solutions for direct amyloid typing.
  • To highlight the potential of proteomics in characterizing amyloid deposits.
  • To discuss proteomic methods for assessing circulating amyloidogenic proteins.

Main Methods:

  • Proteomics, utilizing mass spectrometry, comprehensively analyzes proteins in biological samples.
  • Review of various proposed proteomic approaches for amyloid typing.
  • Description of proteomic methods for evaluating circulating amyloidogenic proteins.

Main Results:

  • Proteomics has demonstrated significant potential in identifying amyloid deposit composition.
  • This approach aids in studying molecular features of amyloidogenic precursors.
  • Proteomics has revolutionized clinical amyloid typing.

Conclusions:

  • Proteomics provides a powerful tool for accurate amyloid typing.
  • The application of proteomics enhances the understanding and management of amyloidoses.
  • Further integration of proteomic methods is recommended for clinical practice.